We are live on ! Find out more
Samlyn Capital

Samlyn Capital Portfolio holdings

AUM $6.14B Turnover 48.04%
1-Year Est. Return 42.05%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.19B
AUM Growth
-$467M
Cap. Flow
-$654M
Cap. Flow %
-15.61%
Top 10 Hldgs %
30.64%
Holding
140
New
55
Increased
21
Reduced
30
Closed
30
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$61.5M
2
ULTA icon
Ulta Beauty
ULTA
+$58.8M
3
AGN
Allergan plc
AGN
+$51.8M
4
EA icon
Electronic Arts
EA
+$51.1M
5
HCA icon
HCA Healthcare
HCA
+$50.4M

Sector Composition

Rank Sector Weight
1 Healthcare 19.31%
2 Consumer Discretionary 16.64%
3 Financials 14.59%
4 Technology 9.5%
5 Industrials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ARMK icon
1
Aramark
ARMK
$14.2B
$233M 5.57%
9,662,590
+27,015
+0.3% +$650K
2014 Q4
6 quarters
AMJ icon
2
CALL
DELISTED
JPMorgan Alerian MLP Index ETN
AMJ
$159M 3.8%
5,000,000
– –
2016 Q1
1 quarter
AGN
3
DELISTED
Allergan plc
AGN
$150M 3.59%
650,295
+224,515
+53% +$51.8M
2013 Q2
12 quarters
STZ icon
4
Constellation Brands
STZ
$24.8B
$140M 3.35%
847,879
-374,883
-31% -$58.7M
2013 Q2
12 quarters
BIIB icon
5
Biogen
BIIB
$37.6B
$128M 3.07%
530,927
+233,420
+78% +$61.5M
2015 Q3
3 quarters
APD icon
6
Air Products & Chemicals
APD
$70.4B
$106M 2.53%
807,075
-39,348
-5% -$5.24M
2014 Q1
9 quarters
CLGX
7
DELISTED
CoreLogic
CLGX
$94M 2.24%
2,443,689
-54,569
-2% -$1.99M
2013 Q2
12 quarters
VLO icon
8
Valero Energy
VLO
$103B
$93.4M 2.23%
1,831,866
+522,000
+40% +$29.5M
2015 Q1
5 quarters
EVHC
9
DELISTED
Envision Healthcare Holdings
EVHC
$91.4M 2.18%
1,202,666
-153,869
-11% -$10.9M
2014 Q1
9 quarters
UNH icon
10
UnitedHealth
UNH
$368B
$87.5M 2.09%
619,943
-26,486
-4% -$3.53M
2015 Q4
2 quarters
HDB icon
11
HDFC Bank
HDB
$135B
$85.8M 2.05%
5,169,592
-189,568
-4% -$3.02M
2014 Q4
6 quarters
AET
12
DELISTED
Aetna Inc
AET
$82.9M 1.98%
679,170
-271,193
-29% -$31.1M
2015 Q1
5 quarters
EMC icon
13
DELISTED
EMC
EMC
$76.5M 1.83%
2,816,665
-147,900
-5% -$4M
2016 Q1
1 quarter
AGN
14
PUT
DELISTED
Allergan plc
AGN
$75.1M 1.79%
+325,000
New +$74.9M
2016 Q2
0 quarters
LH icon
15
Labcorp
LH
$30B
$74M 1.77%
661,186
+3,520
+0.5% +$379K
2014 Q4
6 quarters
ALL icon
16
Allstate
ALL
$67B
$74M 1.77%
1,057,607
+74,000
+8% +$4.96M
2013 Q4
10 quarters
DBRG icon
17
DELISTED
DigitalBridge
DBRG
$73M 1.74%
1,788,532
+191,125
+12% +$9.09M
2014 Q3
7 quarters
AMZN icon
18
Amazon
AMZN
$2.81T
$72.6M 1.73%
2,027,900
+23,340
+1% +$789K
2016 Q1
1 quarter
MEOH icon
19
Methanex
MEOH
$5.2B
$67M 1.6%
2,302,158
-437,242
-16% -$14M
2013 Q4
10 quarters
SC
20
DELISTED
Santander Consumer USA Holdings
SC
$66.1M 1.58%
6,397,120
+302,171
+5% +$3.51M
2014 Q3
7 quarters
ULTA icon
21
Ulta Beauty
ULTA
$28B
$65.8M 1.57%
+270,205
New +$58.8M
2016 Q2
0 quarters
EXPE icon
22
Expedia Group
EXPE
$30.2B
$65.8M 1.57%
618,703
-121,209
-16% -$13.2M
2015 Q3
3 quarters
MCK icon
23
McKesson
MCK
$128B
$65.5M 1.56%
350,767
+47,995
+16% +$8.42M
2014 Q4
6 quarters
RACE icon
24
Ferrari
RACE
$71B
$65.2M 1.56%
1,591,744
+268,844
+20% +$11.4M
2015 Q4
2 quarters
KATE
25
DELISTED
Kate Spade & Co
KATE
$58.6M 1.4%
2,843,657
-896,343
-24% -$20.4M
2013 Q2
12 quarters

Similar funds

Samlyn Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Samlyn Capital held 140 positions worth $4.19B, down 10% from $4.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Samlyn Capital withdrew a net $654M in Q2 2016, closing 30 positions and reducing 30 holdings. Its most notable exit was Regions Financial, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Samlyn Capital opened a new position in Ulta Beauty worth $65.8M.

  • Samlyn Capital's largest Q2 2016 buy was Ulta Beauty: 270,205 shares worth $65.8M.
  • Samlyn Capital added most to Biogen in Q2 2016, an estimated $61.5M increase.
  • Samlyn Capital's biggest Q2 2016 reduction was KeyCorp, cutting an estimated $123M.
  • Samlyn Capital fully exited Regions Financial in Q2 2016, selling an estimated $105M.
  • Samlyn Capital's ten largest holdings make up 31% of its $4.19B portfolio in Q2 2016.
  • Samlyn Capital opened 55 new positions and closed 30 in Q2 2016.
  • Samlyn Capital's portfolio value fell 10% quarter-over-quarter to $4.19B.

Based on Samlyn Capital's 13F filing for Q2 2016, filed 15 Aug 2016.